M Biopsy /SureCore Automatic Disposable Biopsy Needle, M Biopsy /SureCore Semi-Automatic Disposable Biopsy Needle, M Biopsy /SureAim Coaxial Biopsy Needle
510(k) K222865
Active
Valid until
Not listed
FDA recalls
None foundTrust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE 510(k) | NumberK222865 | Date3 Apr 2023 | StatusActive |
| European Union | CE/MDD EUDAMED | Number— | Date— | StatusActive |
| European Union | CE/MDR EUDAMED | Number— | Date— | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- 510(k) Number
- FDA Product Code
- KNW
- FDA applicant
- Canyon Medical, Inc.
- Device Class
- Class II
- Regulation
- 21 CFR Part 876.1075
- Advisory Committee
- Gastroenterology, Urology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The M Biopsy SureCore and SureAim needles are disposable biopsy instruments designed for percutaneous tissue acquisition. These devices fall under the category of biopsy needles, featuring automated or semi-automated mechanisms to facilitate precise tissue sampling in clinical settings. The SureCore models provide automatic or semi-automatic actuation for controlled core needle biopsy procedures, while the SureAim Coaxial Biopsy Needle incorporates a coaxial design for enhanced accuracy during sampling.
These devices are intended for single-use and are supplied sterile, ensuring compliance with medical standards for aseptic procedures. They are classified under the product code KNW and are regulated under FDA 510(k) clearance, MDD, and MDR. The needles are available in various configurations to accommodate different clinical applications, with no specific MRI safety restrictions noted. Proper storage adheres to standard sterile packaging guidelines to maintain integrity until use.
Other devices from Canyon Medical Inc.
Questions
AI-generated answers, 18 Sep 2026
Are these biopsy needles designed for reuse or are they intended for single-use only?
These devices are explicitly designed for single-use only. The product description and specifications confirm they are supplied sterile and intended to maintain aseptic standards during clinical procedures, which is a key requirement for disposable medical instruments.
What types of clinical procedures are these needles primarily used for, and how do their designs differ?
These needles are designed for percutaneous tissue acquisition, commonly used in core needle biopsy procedures. The SureCore models (automatic and semi-automatic) provide controlled actuation for precise sampling, while the SureAim Coaxial Biopsy Needle features a coaxial design to enhance accuracy during tissue extraction. The design differences cater to varying clinical needs, such as improved guidance or automated force application.
How should these needles be stored to ensure they remain sterile until use?
The needles must be stored according to standard sterile packaging guidelines to preserve their integrity. Since they are supplied sterile and intended for single-use, the packaging should remain unopened and protected from contamination until immediately before use, following manufacturer-recommended storage conditions.
Are there any specific size or model variations available for these biopsy needles, and how might they be selected?
While the exact sizes or model variations aren’t detailed in the provided data, the description mentions these needles are available in various configurations to accommodate different clinical applications. Selection would typically depend on factors like tissue type, target depth, and procedural requirements, though specific gauges or lengths would need to be confirmed with the manufacturer or product documentation.
What regulatory pathways have these devices undergone, and which committees were involved in their review?
These devices have undergone FDA 510(k) clearance, MDD (Medical Device Directive), and MDR (Medical Device Regulation) reviews. The FDA submission was reviewed by the Gastroenterology and Urology advisory committees (listed under the GU review panel), with a decision classified as *Substantially Equivalent* (SESE) under the traditional clearance type.